Adenosine Deaminase Inhibition Prevents Clostridium difficile Toxin A-Induced Enteritis in Mice

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Infection and Immunity

• Publication date

  2010-11-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01159-10PMID 21115723PMCID PMC3028843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Toxin B is essential for virulence of Clostridium difficile

  2009cited by this paper
• The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice.

  2009cited by this paper
• Fucoidin Prevents Clostridium difficile Toxin-A-Induced Ileal Enteritis in Mice

  2008cited by this paper
• Clostridium difficile--more difficult than ever.

  2008cited by this paper
• Enhanced mast cell activation in mice deficient in the A2b adenosine receptor

  2007cited by this paper
• The challenges posed by reemerging Clostridium difficile infection.

  2007cited by this paper
• Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster

  2007cited by this paper
• Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice.

  2006cited by this paper
• Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

  2006cited by this paper
• Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis

  2006cited by this paper
• The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

  2006cited by this paper
• Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-α Release by Reducing Calcium-Dependent Activation of Nuclear Factor-κB and Extracellular Signal-Regulated Kinase 1/2

  2006cited by this paper
• Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor

  2005cited by this paper
• Clostridium difficile Toxin A Induces Intestinal Epithelial Cell Apoptosis and Damage: Role of Gln and Ala-Gln in Toxin A Effects

  2005cited by this paper
• Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

  2005cited by this paper
• Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.

  2005cited by this paper
• Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells.

  2005cited by this paper
• Specific Inhibition of Nuclear Factor-κB–Dependent Inflammatory Responses by Cell Type-Specific Mechanisms upon A2A Adenosine Receptor Gene Transfer

  2004cited by this paper
• Adenosine: an endogenous regulator of innate immunity.

  2004influential reference
• PTX3 function as an opsonin for the dectin‐1‐dependent internalization of zymosan by macrophages

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells

  2003cited by this paper
• Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells.

  2002cited by this paper
• Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

  2002cited by this paper
• Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury.

  2002cited by this paper
• Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function.

  2002cited by this paper
• Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors.

  2002cited by this paper
• Clinical practice. Antibiotic-associated diarrhea.

  2002cited by this paper
• Oxidant stress, nitric oxide and vascular disease

  2002cited by this paper
• Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.

  2001cited by this paper
• Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Oxidative Stress, Nitric Oxide, and Vascular Disease

  2001cited by this paper
• Adenosine kinase inhibitor GP515 improves experimental colitis in mice.

  2001cited by this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• TSG‐14 transgenic mice have improved survival to endotoxemia and to CLP‐induced sepsis

  2001cited by this paper
• Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

  2001cited by this paper
• Suppression of TNF‐α production in human mononuclear cells by an adenosine kinase inhibitor

  2000cited by this paper
• Inhibition of small G proteins of the Rho family by statins or Clostridium difficile toxin B enhances cytokine‐mediated induction of NO synthase II

  2000cited by this paper
• Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells*

  2000cited by this paper
• Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

  2000cited by this paper
• Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells.

  2000cited by this paper
• Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.

  2000cited by this paper
• Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression.

  1999cited by this paper
• Nerves and Intestinal Mast Cells Modulate Responses to Enterotoxins.

  1998cited by this paper
• Receptors for purines and pyrimidines.

  1998cited by this paper
• Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages.

  1997cited by this paper
• Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.

  1997influential reference
• Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin.

  1996cited by this paper
• Contribution of interleukin‐1β to the inflammation‐induced increase in nerve growth factor levels and inflammatory hyperalgesia

  1995cited by this paper
• Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

  1994cited by this paper
• Adenosine, an endogenous anti-inflammatory agent.

  1994influential reference
• Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B

  1991cited by this paper
• Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

  1990cited by this paper
• Cellular and extracellular myeloperoxidase in pyogenic inflammation.

  1982cited by this paper
• The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics.

  1981cited by this paper
• Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin

  1980cited by this paper
• Human adenosine deaminase. Stoichiometry of the adenosine deaminase-binding protein complex.

  1979cited by this paper
• Partial purification of a toxin found in hamsters with antibiotic-associated colitis. Reversible binding of the toxin by cholestyramine.

  1978cited by this paper
• Human adenosine deaminase. Distribution and properties.

  1976cited by this paper
• difficile: Its Disease and Toxins

  year unknowncited by this paper

• Clostridioides difficile meets the adenosine system: the art of manipulating host homeostasis

  2025influential citation
• Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation

  2025cites this paper
• Polymorphonuclear neutrophil depletion in ileal tissues reduces the immunopathology induced by Clostridioides difficile toxins.

  2025cites this paper
• The Role of Adenosine in γδ T-Cell Regulation of Th17 Responses in Experimental Autoimmune Uveitis

  2023cites this paper
• Clostridioides difficile in Latin America: A comprehensive review of literature (1984-2021).

  2022cites this paper
• Antifibrotic Effects of Quercetin and Adenosine Deaminase Inhibitor on Thioacetamide-Induced Liver Fibrosis Mediated By P53 and NF-Kβ Gene Expression

  2021cites this paper
• The protective effects of adenosine deaminase inhibitor and ouercetin against hepatocellular carcinoma induced by thioacetamide in male rats via downregulation of iNOS, Ki67 and Pan-CK

  2021cites this paper
• Chemotactic factor inducing Interleukin-8 (IL8) gene is transcriptionally elevated in experimental enterotoxaemia in goats caused by Clostridium perfringens type D

  2021cites this paper
• Functional prediction, characterization, and categorization of operome from Acetoanaerobium sticklandii DSM 519.

  2020cites this paper
• In vivo animal models confirm an increased virulence potential and pathogenicity of the NAP1/RT027/ST01 genotype within the Clostridium difficile MLST Clade 2

  2020cites this paper
• Clostridioides difficile Toxin A-Induced Wnt/β-Catenin Pathway Inhibition Is Mediated by Rac1 Glucosylation

  2020cites this paper
• Clostridium difficile toxins or infection induce upregulation of adenosine receptors and IL-6 with early pro-inflammatory and late anti-inflammatory pattern

  2020cites this paper
• Adenosine deaminase inhibition.

  2019cites this paper
• Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.

  2018cites this paper
• Neural mechanisms involved in enterotoxin- induced intestinal hypersecretion

  2017cites this paper
• Traditional Chinese Medicine QPYF as Preventive Treatment for Clostridium difficile Associated Diarrhea in a Mouse Model

  2016cites this paper
• This information is current as Uveitis Induced Mouse Experimental Autoimmune Regulation of Adenosine Deaminase on

  2016cites this paper
• A MLST Clade 2 Clostridium difficile strain with a variant TcdB induces severe inflammatory and oxidative response associated with mucosal disruption.

  2016cites this paper
• Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis

  2016cites this paper
• Emergence of an Outbreak-Associated Clostridium difficile Variant with Increased Virulence

  2015cites this paper
• Adenosine and inflammation: what's new on the horizon?

  2014cites this paper
• Epithelial Cells-Catenin Signaling in Intestinal β Wnt / Clostridium difficile Toxin A Attenuates

  2014cites this paper
• Clostridium difficile Toxin A Attenuates Wnt/β-Catenin Signaling in Intestinal Epithelial Cells

  2014cites this paper
• C. difficile -induced colitis in mice is independent of leukotrienes

  2014cites this paper
• Clostridium difficile-induced colitis in mice is independent of leukotrienes.

  2014cites this paper
• Clostridium difficile infection susceptibility is controlled by alterations to the gut microbiota before and after antibiotic exposure

  2014cites this paper
• Clostridium difficile Toxin A Attenuates Wnt/β-Catenin Signaling in Intestinal Epithelial Cells

  2014cites this paper
• Reverse Pharmacognosy: A Tool to Accelerate the Discovery of New Bioactive Food Ingredients

  2014cites this paper
• The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.

  2013cites this paper
• Attenuation of Clostridium difficile toxin‐induced damage to epithelial barrier by ecto‐5′‐nucleotidase (CD73) and adenosine receptor signaling

  2013cites this paper
• The P2Y6 Receptor Mediates Clostridium difficile Toxin-Induced CXCL8/IL-8 Production and Intestinal Epithelial Barrier Dysfunction

  2013cites this paper
• Intrarectal Instillation of Clostridium difficile Toxin A Triggers Colonic Inflammation and Tissue Damage: Development of a Novel and Efficient Mouse Model of Clostridium difficile Toxin Exposure

  2012cites this paper
• Models for the study of Clostridium difficile infection

  2012cites this paper
• Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment

  2012influential citation
• Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.

  2012cites this paper
• MAPK-Activated Protein Kinase 2 Contributes to Clostridium difficile-Associated Inflammation

  2012cites this paper
• Adenosine in the inflamed gut: a Janus faced compound.

  2011cites this paper